203 related articles for article (PubMed ID: 25662499)
1. Plasma hydrogenated cationic detonation nanodiamonds efficiently deliver to human cells in culture functional siRNA targeting the Ewing sarcoma junction oncogene.
Bertrand JR; Pioche-Durieu C; Ayala J; Petit T; Girard HA; Malvy CP; Le Cam E; Treussart F; Arnault JC
Biomaterials; 2015 Mar; 45():93-8. PubMed ID: 25662499
[TBL] [Abstract][Full Text] [Related]
2. Synthetic siRNA targeting the breakpoint of EWS/Fli-1 inhibits growth of Ewing sarcoma xenografts in a mouse model.
Takigami I; Ohno T; Kitade Y; Hara A; Nagano A; Kawai G; Saitou M; Matsuhashi A; Yamada K; Shimizu K
Int J Cancer; 2011 Jan; 128(1):216-26. PubMed ID: 20648560
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of siRNA nanocapsules targeted against the EWS-Fli1 oncogene in Ewing sarcoma.
Toub N; Bertrand JR; Tamaddon A; Elhamess H; Hillaireau H; Maksimenko A; Maccario J; Malvy C; Fattal E; Couvreur P
Pharm Res; 2006 May; 23(5):892-900. PubMed ID: 16715379
[TBL] [Abstract][Full Text] [Related]
4. EWS-FLI-1 regulates the neuronal repressor gene REST, which controls Ewing sarcoma growth and vascular morphology.
Zhou Z; Yu L; Kleinerman ES
Cancer; 2014 Feb; 120(4):579-88. PubMed ID: 24415532
[TBL] [Abstract][Full Text] [Related]
5. Systems biology of Ewing sarcoma: a network model of EWS-FLI1 effect on proliferation and apoptosis.
Stoll G; Surdez D; Tirode F; Laud K; Barillot E; Zinovyev A; Delattre O
Nucleic Acids Res; 2013 Oct; 41(19):8853-71. PubMed ID: 23935076
[TBL] [Abstract][Full Text] [Related]
6. EWS/FLI-1 silencing and gene profiling of Ewing cells reveal downstream oncogenic pathways and a crucial role for repression of insulin-like growth factor binding protein 3.
Prieur A; Tirode F; Cohen P; Delattre O
Mol Cell Biol; 2004 Aug; 24(16):7275-83. PubMed ID: 15282325
[TBL] [Abstract][Full Text] [Related]
7. Nanodiamond as a vector for siRNA delivery to Ewing sarcoma cells.
Alhaddad A; Adam MP; Botsoa J; Dantelle G; Perruchas S; Gacoin T; Mansuy C; Lavielle S; Malvy C; Treussart F; Bertrand JR
Small; 2011 Nov; 7(21):3087-95. PubMed ID: 21913326
[TBL] [Abstract][Full Text] [Related]
8. PRAS40 is a functionally critical target for EWS repression in Ewing sarcoma.
Huang L; Nakai Y; Kuwahara I; Matsumoto K
Cancer Res; 2012 Mar; 72(5):1260-9. PubMed ID: 22241085
[TBL] [Abstract][Full Text] [Related]
9. EWS/FLI is a Master Regulator of Metabolic Reprogramming in Ewing Sarcoma.
Tanner JM; Bensard C; Wei P; Krah NM; Schell JC; Gardiner J; Schiffman J; Lessnick SL; Rutter J
Mol Cancer Res; 2017 Nov; 15(11):1517-1530. PubMed ID: 28720588
[TBL] [Abstract][Full Text] [Related]
10. Dual targeting of EWS-FLI1 activity and the associated DNA damage response with trabectedin and SN38 synergistically inhibits Ewing sarcoma cell growth.
Grohar PJ; Segars LE; Yeung C; Pommier Y; D'Incalci M; Mendoza A; Helman LJ
Clin Cancer Res; 2014 Mar; 20(5):1190-203. PubMed ID: 24277455
[TBL] [Abstract][Full Text] [Related]
11. Ewing sarcoma EWS protein regulates midzone formation by recruiting Aurora B kinase to the midzone.
Park H; Turkalo TK; Nelson K; Folmsbee SS; Robb C; Roper B; Azuma M
Cell Cycle; 2014; 13(15):2391-9. PubMed ID: 25483190
[TBL] [Abstract][Full Text] [Related]
12. Ewing sarcoma cells secrete EWS/Fli-1 fusion mRNA via microvesicles.
Tsugita M; Yamada N; Noguchi S; Yamada K; Moritake H; Shimizu K; Akao Y; Ohno T
PLoS One; 2013; 8(10):e77416. PubMed ID: 24124617
[TBL] [Abstract][Full Text] [Related]
13. EWS/FLI mediated reprogramming of 3D chromatin promotes an altered transcriptional state in Ewing sarcoma.
Showpnil IA; Selich-Anderson J; Taslim C; Boone MA; Crow JC; Theisen ER; Lessnick SL
Nucleic Acids Res; 2022 Sep; 50(17):9814-9837. PubMed ID: 36124657
[TBL] [Abstract][Full Text] [Related]
14. RUNX3 facilitates growth of Ewing sarcoma cells.
Bledsoe KL; McGee-Lawrence ME; Camilleri ET; Wang X; Riester SM; van Wijnen AJ; Oliveira AM; Westendorf JJ
J Cell Physiol; 2014 Dec; 229(12):2049-56. PubMed ID: 24812032
[TBL] [Abstract][Full Text] [Related]
15. Cruel fusion: What a young man's death means for childhood cancer.
Ledford H
Nature; 2017 Mar; 543(7647):608-611. PubMed ID: 28358102
[No Abstract] [Full Text] [Related]
16. A Druggable Rheostat for Ewing Sarcoma?
Weiss KR; Bailey KM
Clin Cancer Res; 2022 Oct; 28(20):4360-4362. PubMed ID: 35921177
[TBL] [Abstract][Full Text] [Related]
17. Influence of the internalization pathway on the efficacy of siRNA delivery by cationic fluorescent nanodiamonds in the Ewing sarcoma cell model.
Alhaddad A; Durieu C; Dantelle G; Le Cam E; Malvy C; Treussart F; Bertrand JR
PLoS One; 2012; 7(12):e52207. PubMed ID: 23284935
[TBL] [Abstract][Full Text] [Related]
18. The Promoter-Associated Noncoding RNA
Palombo R; Frisone P; Fidaleo M; Mercatelli N; Sette C; Paronetto MP
Cancer Res; 2019 Jul; 79(14):3570-3582. PubMed ID: 31072811
[TBL] [Abstract][Full Text] [Related]
19. EWS-FLI1-regulated Serine Synthesis and Exogenous Serine are Necessary for Ewing Sarcoma Cellular Proliferation and Tumor Growth.
Issaq SH; Mendoza A; Kidner R; Rosales TI; Duveau DY; Heske CM; Rohde JM; Boxer MB; Thomas CJ; DeBerardinis RJ; Helman LJ
Mol Cancer Ther; 2020 Jul; 19(7):1520-1529. PubMed ID: 32371575
[TBL] [Abstract][Full Text] [Related]
20. Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis.
Showpnil IA; Miller KR; Taslim C; Pishas KI; Lessnick SL; Theisen ER
J Vis Exp; 2020 Jun; (160):. PubMed ID: 32658189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]